{
  "id": "mhgap#risk_safety_7a7fd855",
  "content": "TABLE 1: Medication Chart\nCLASS / INDICATION MEDICATION DOSING SIDE EFFECTS CONTRAINDICATIONS / CAUTIONS\nBENZODIAZEPINES Diazepam 10-20 mg for observable features of alcohol with- Sedation and respiratory depression which can Do not use in people who are sedated. Beware of\ndrawal or stimulant intoxication every 2 hours until be life threatening. Prolonged use can lead to combining with other sedatives. Patients should not\nTo treat alcohol withdrawal,\nfeatures of alcohol withdrawal/stimulant intoxication dependence. drive. Duration of effect may be prolonged in persons\nstimulant intoxication, and\nare no longer observable or the person is lightly with severe liver disease. Supervise dosing to minimise\npsychosis\nsedated. Lower doses (up to 10 mg four times a day) the risk of: diversion (i.e. selling the medication to\nfor alcohol withdrawal in an outpatient setting. somebody else).\nOPIOID ANTAGONISTS Naloxone 0.4-2 mg i.v., i.m., subcutaneous or intranasal. Discomfort or withdrawal symptoms may result.\nRepeat doses as needed.\nTo treat opioid overdose\nVITAMINS Thiamine 100 mg p.o. daily for 5 days to prevent Wernicke’s\n(Vitamin B1) encephalopathy.\nTo prevent or treat Wernicke’s\n100 mg – 500 mg i.v. or i.m. two to three times\nencephalopathy\ndaily for 3-5 days to treat Wernicke’s encephalopathy.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety TABLE 1: Medication Chart\nCLASS / INDICATION MEDICATION DOSING SIDE EFFECTS CONTRAINDICATIONS / CAUTIONS\nBENZODIAZEPINES Diazepam 10-20 mg for observable features of alcohol with- Sedation and respiratory depression which can Do not use in people who are sedated. Beware of\ndrawal or stimulant intoxication every 2 hours until be life threatening. Prolonged use can lead to combining with other sedatives. Patients should not\nTo treat alcohol withdrawal,\nfeatures of alcohol withdrawal/stimulant intoxication dependence. drive. Duration of effect may be prolonged in persons\nstimulant intoxication, and\nare no longer observable or the person is lightly with severe liver disease. Supervise dosing to minimise\npsychosis\nsedated. Lower doses (up to 10 mg four times a day) the risk of: diversion (i.e. selling the medication to\nfor alcohol withdrawal in an outpatient setting. somebody else).\nOPIOID ANTAGONISTS Naloxone 0.4-2 mg i.v., i.m., subcutaneous or intranasal. Discomfort or withdrawal symptoms may result.\nRepeat doses as needed.\nTo treat opioid overdose\nVITAMINS Thiamine 100 mg p.o. daily for 5 days to prevent Wernicke’s\n(Vitamin B1) encephalopathy.\nTo prevent or treat Wernicke’s\n100 mg – 500 mg i.v. or i.m. two to three times\nencephalopathy\ndaily for 3-5 days to treat Wernicke’s encephalopathy. Table 1: medication chart\nclass / indication medication dosing side effects contraindications / cautions\nbenzodiazepines diazepam 10-20 mg for observable features of alcohol with- sedation and respiratory trầm cảm which ..."
}